(Q52851594)

English

Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid.

scientific article published on 13 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

cerebrospinal fluid

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

P Sarchielli

1

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

I Rainero

2

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

F Coppola

3

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

C Rossi

4

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

Ml Mancini

5

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

L Pinessi

6

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

P Calabresi

7

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

language of work or name

0 references

publication date

13 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

28

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

7

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

714-722

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

Epidemiology of headache in Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Epidemiology of chronic daily headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Modifiable risk factors for migraine progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Medication-overuse headache: similarities with drug addiction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Pathophysiology and management of transformed migraine and medication overuse headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Attenuated defense response and low basal blood pressure in orexin knockout mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

The hypothalamic orexinergic system: pain and primary headaches.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Distinct recognition of OX1 and OX2 receptors by orexin peptides.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Differential expression of orexin receptors 1 and 2 in the rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Orexin A-like immunoreactivity in the rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Descending control of pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Neuropeptide expression in rat paraventricular hypothalamic neurons that project to the spinal cord.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Orexin-A, an hypothalamic peptide with analgesic properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

New appendix criteria open for a broader concept of chronic migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Hypothalamic involvement in chronic migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Salivary cortisol, dehydroepiandrosterone-sulphate (DHEA-S) and testosterone in women with chronic migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Obesity, migraine, and chronic migraine: possible mechanisms of interaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

A role for lateral hypothalamic orexin neurons in reward seeking

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF n

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Lateral hypothalamic neuropeptides in reward and drug addiction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

The corticotropin-releasing factor-hypocretin connection: implications in stress response and addiction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Corticotropin-releasing factor receptor antagonists in affective disorders and drug dependence-- an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Orexin: a gatekeeper of addiction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2008.01566.X

21 January 2018

Identifiers

10.1111/J.1468-2982.2008.01566.X

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/18479471

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52851594&oldid=1078656418"